药物性帕金森综合征（DIP）管理的最新观点：来自临床的见解
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
作者信息
Feldman Matthew, Marmol Sarah, Margolesky Jason
机构信息
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
出版信息
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
Abstract
Parkinsonism refers to the clinical combination of bradykinesia, rigidity, tremor, and postural instability. Parkinsonism is often neurodegenerative, but it can be secondary or iatrogenic, as in drug-induced parkinsonism (DIP), which is the topic of this review. We review the pathophysiology of DIP, differentiate DIP and idiopathic Parkinson's disease (PD), list culprit medications in the development of DIP, discuss the diagnosis of DIP as well as the motor and nonmotor signs and symptoms that can help with differentiation of DIP and PD, and detail the management of DIP.
摘要
帕金森综合征是指运动迟缓、肌强直、震颤和姿势不稳的临床组合。帕金森综合征通常是神经退行性疾病，但也可能是继发性或医源性的，如药物性帕金森综合征（DIP），这是本综述的主题。我们回顾了DIP的病理生理学，区分了DIP和特发性帕金森病（PD），列出了导致DIP的罪魁祸首药物，讨论了DIP的诊断以及有助于区分DIP和PD的运动和非运动体征及症状，并详细介绍了DIP的管理。
相似文献
1
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
2
Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.
J Clin Neurol. 2022 May;18(3):259-270. doi: 10.3988/jcn.2022.18.3.259.
3
Drug-induced parkinsonism.
J Clin Neurol. 2012 Mar;8(1):15-21. doi: 10.3988/jcn.2012.8.1.15. Epub 2012 Mar 31.
4
Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Neurol Sci. 2017 Feb;38(2):319-324. doi: 10.1007/s10072-016-2771-y. Epub 2016 Nov 16.
5
Drug-induced parkinsonism: diagnosis and treatment.
Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25.
6
Drug-induced parkinsonism in the elderly: incidence, management and prevention.
Drugs Aging. 2012 Feb 1;29(2):105-18. doi: 10.2165/11598540-000000000-00000.
7
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Mov Disord. 2006 Apr;21(4):510-4. doi: 10.1002/mds.20748.
8
Drug-induced parkinsonism.
Curr Treat Options Neurol. 2009 May;11(3):162-9. doi: 10.1007/s11940-009-0019-3.
9
Parkinsonism in the psychiatric setting: an update on clinical differentiation and management.
BMJ Neurol Open. 2020 Jan 27;2(1):e000034. doi: 10.1136/bmjno-2019-000034. eCollection 2020.
10
Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
Parkinsonism Relat Disord. 2018 Jan;46:36-40. doi: 10.1016/j.parkreldis.2017.10.011. Epub 2017 Oct 19.
引用本文的文献
1
Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism.
Front Aging Neurosci. 2025 Jul 9;17:1566785. doi: 10.3389/fnagi.2025.1566785. eCollection 2025.
2
Drug-Induced Parkinsonism or Parkinson's Disease: A Diagnostic Challenge in a Psychiatric Patient.
Cureus. 2025 Jul 17;17(7):e88177. doi: 10.7759/cureus.88177. eCollection 2025 Jul.
3
Neuroimaging Techniques in Differentiating Parkinson's Disease from Drug-Induced Parkinsonism: A Comprehensive Review.
Clin Pract. 2023 Nov 15;13(6):1427-1448. doi: 10.3390/clinpract13060128.
4
Overview of Movement Disorders Secondary to Drugs.
Clin Pract. 2023 Aug 18;13(4):959-976. doi: 10.3390/clinpract13040087.
本文引用的文献
1
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism.
NPJ Parkinsons Dis. 2022 Apr 28;8(1):53. doi: 10.1038/s41531-022-00309-8.
2
Clozapine-Induced Hypersalivation Treated with Sulpiride - Is It a Solution?
Psychiatr Danub. 2021 Spring;33(Suppl 4):1230-1232.
3
Use of antipsychotics and long-term risk of parkinsonism.
Neurol Sci. 2022 Apr;43(4):2545-2553. doi: 10.1007/s10072-021-05650-z. Epub 2021 Oct 15.
4
Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies.
PLoS One. 2021 Sep 10;16(9):e0257129. doi: 10.1371/journal.pone.0257129. eCollection 2021.
5
Valbenazine-induced parkinsonism.
Parkinsonism Relat Disord. 2020 Jan;70:13-14. doi: 10.1016/j.parkreldis.2019.11.021. Epub 2019 Nov 25.
6
Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism.
Mov Disord Clin Pract. 2015 Dec 18;3(3):268-274. doi: 10.1002/mdc3.12281. eCollection 2016 May-Jun.
7
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
8
DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
Parkinsonism Relat Disord. 2018 Aug;53:37-41. doi: 10.1016/j.parkreldis.2018.04.037. Epub 2018 May 5.
9
Tacrolimus-induced parkinsonism in a patient after liver transplantation - case report.
BMC Neurol. 2018 Apr 20;18(1):44. doi: 10.1186/s12883-018-1052-1.
10
Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
J Neurol Sci. 2018 Jun 15;389:67-75. doi: 10.1016/j.jns.2018.02.010. Epub 2018 Feb 5.
Zotero 插件